SEC Form D · filed November 5, 2019
Viracta Therapeutics, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Richard Ghalie · Cardiff, CADirectorSamuel Murphy · Cardiff, CADirectorDavid Slack · Cardiff, CAExecIvor Royston · Cardiff, CAExec · DirectorDaniel Chevallard · Cardiff, CAExecStandish Fleming · Cardiff, CADirectorJames Woody · Cardiff, CADirectorBarry Simon · Cardiff, CADirectorMichael Huang · Cardiff, CADirectorJean-Francois J. Legault · Cranberry Township, PADirectorKripa Varanasi · WOBURN, MADirectorMark Little · WOBURN, MADirectorBritta P. Mccorduck · Charlotte, NCExecRajesh Unni · WOBURN, MAExec · DirectorDavid Williams · New York, NYExecSamuel Murphy · Cardiff, CADirectorClare F. Wood · London, United KingdomDirectorTerrence D. Yodaiken · London, United KingdomDirectorFernando C. Verboonen · Rio de Janeiro, GuernseyDirectorWolney C. Betiol · Rio de Janeiro, GuernseyExecKen T. Denman · La Jolla, CAExec · DirectorLegendary Lodging VAB QOZ Manager, LLC · Fargo, NDDirectorAllen Faires · Columbus, OHDirectorBrandon R. Turner · Kihei, HIDirectorLansdowne General Partner I Limited · Grand Cayman, Cayman IslandsDirectorThomas R. Chamberlain · St Saviours, Y7ExecAnthony Meyer · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗